There are 105 resources available
Where it was logical to go: The ESMO economic model for cancer medicines
Presenter: Panagiotis Kanavos
Session: Connecting the dots: The ESMO vision on the value of cancer medicines
Resources:
Slides
Webcast
What we need to bring into the equation: The ESMO ESCAT
Presenter: Joaquin Mateo
Session: Connecting the dots: The ESMO vision on the value of cancer medicines
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Josep Tabernero
Session: Connecting the dots: The ESMO vision on the value of cancer medicines
Resources:
Webcast
274O - Health-related quality of life (HRQoL) changes with veliparib in patients (pts) with metastatic or locally advanced breast cancer in the phase III BROCADE 3 study
Presenter: Michael Friedlander
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Abstract
Slides
Webcast
275O - Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM)
Presenter: Volkmar Mueller
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Abstract
Slides
Webcast
276O - Pooled analysis of patient (pt)-reported quality of life (QOL) in the MONALEESA (ML)-2, -3, and -7 trials of ribociclib (RIB) plus endocrine therapy (ET) to treat hormone receptor–positive, HER2-negative (HR+/HER2−) advanced breast cancer (ABC)
Presenter: Peter A. Fasching
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Abstract
Slides
Webcast
LBA19 - GEICAM/2014-12 (FLIPPER) study: First analysis from a randomized phase II trial of fulvestrant (F)/palbociclib (P) versus (vs) F/placebo (PL) as first-line therapy in postmenopausal women with HR (hormone receptor)+/HER2– endocrine sensitive advanced breast cancer (ABC)
Presenter: Joan Albanell
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Abstract
Slides
Webcast
LBA87 - A pragmatic cluster-randomized trial of ambulatory toxicity management in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer (AToM)
Presenter: Monika Krzyzanowska
Session: Proffered Paper - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1809O - TRheuMa registry provides real world data on rheumatic immune-related adverse events
Presenter: Karolina Benesova
Session: Proffered Paper - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1568O - Quality of life in cancer patients treated with immune checkpoint inhibitors: A meta-analysis
Presenter: Brian Gonzalez
Session: Proffered Paper - Supportive and palliative care
Resources:
Abstract
Slides
Webcast